Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Cancer Treatment Reports|May 1, 1976
Study of cytosine arabinoside (NSC-63878) synchronization plus vincristine (NSC-67574), prednisone (NSC-10023), and L-asparaginase (NSC-109229) for remission induction in advanced acute leukemia in childrenW W Sutow, D Thomas, C P Steuber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group studyD H Mahoney, J J Shuster, R Nitschke, et al.
Leukemia Research|January 1, 1986
Effect of retinoic acid on myeloid antigen expression and clonal growth of leukemic cells from children with acute non lymphocytic leukemia--a Pediatric Oncology Group StudyH W Findley, C P Steuber, F B Ruymann, et al.
Medical and Pediatric Oncology|January 1, 1984
Impact of the timing of triple intrathecal therapy on remission induction in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group studyE Hvizdala, D H Berry, T Chen, et al.
Leukemia|January 1, 1992
Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology GroupW Crist, J Shuster, T Look, et al.
Blood|August 1, 1990
Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group studyW Crist, A Carroll, J Shuster, et al.
Leukemia|July 29, 2000
Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821M Chang, S C Raimondi, Y Ravindranath, et al.
Medical and Pediatric Oncology|January 1, 1993
Hodgkin's disease associated with central pontine myelinolysisM M Chintagumpala, D H Mahoney, K McClain, et al.
Cancer|January 15, 1985
Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded)M P Sullivan, J Boyett, J Pullen, et al.
Blood|August 15, 1993
Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group studyM J Borowitz, S P Hunger, A J Carroll, et al.
Pageof 7